VEGFR2 expressions in Th1 and CD8+cytotoxic T lymphocytes (CTL) in colon cancer patients.
dc.contributor.author | Artac, Mehmet | |
dc.contributor.author | Ceylan, Ayca | |
dc.contributor.author | Eryilmaz, Melek Karakurt | |
dc.contributor.author | Araz, Murat | |
dc.contributor.author | Karaagac, Mustafa | |
dc.contributor.author | Artac, Hasibe | |
dc.contributor.author | Emiroglu, Melike | |
dc.date.accessioned | 2024-02-23T14:29:11Z | |
dc.date.available | 2024-02-23T14:29:11Z | |
dc.date.issued | 2021 | |
dc.department | NEÜ | en_US |
dc.description | Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 04-08, 2021 -- ELECTR NETWORK | en_US |
dc.description.abstract | [Abstract Not Availabe] | en_US |
dc.description.sponsorship | Amer Soc Clin Oncol | en_US |
dc.description.sponsorship | Scientific Research Projects (BAP) Fund of Selcuk University | en_US |
dc.description.sponsorship | Scientific Research Projects (BAP) Fund of Selcuk University | en_US |
dc.identifier.doi | 10.1200/JCO.2021.39.15_suppl.e15535 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.issue | 15 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.uri | https://doi.org/10.1200/JCO.2021.39.15_suppl.e15535 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/14586 | |
dc.identifier.volume | 39 | en_US |
dc.identifier.wos | WOS:000708120301200 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Journal Of Clinical Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [Keyword Not Available] | en_US |
dc.title | VEGFR2 expressions in Th1 and CD8+cytotoxic T lymphocytes (CTL) in colon cancer patients. | en_US |
dc.type | Conference Object | en_US |